[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Scilex Holding Company, a biopharmaceutical company, focuses on acquiring, developing, and commercializing non-opioid management products for the treatment of acute and chronic pain. It offers ZTlido, a prescription lidocaine topical product for the relief of neuropathic pain related with postherpetic neuralgia, which is a form of post-shingles nerve pain. The company also develops SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trial for the treatment of low back pain; and SP-104 (4.5 mg), a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.", "fullTimeEmployees": 109, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henry H. Ji Ph.D.", "age": 59, "title": "Executive Chairman", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 4345737, "exercisedValue": 0, "unexercisedValue": 4304681}, {"maxAge": 1, "name": "Mr. Jaisim  Shah", "age": 63, "title": "President, CEO & Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 785733, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Ma", "age": 51, "title": "Senior VP & CFO", "yearBorn": 1972, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suketu D. Desai Ph.D.", "age": 57, "title": "CTO & Senior VP", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gigi  DeGuzman", "title": "Executive Director of Administrative Operations & Head of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven F. Lincoln J.D.", "title": "General Counsel & Chief Compliance Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sumant  Rajendran", "title": "Executive Director of Marketing", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mike  Ciaffi", "title": "National Sales Director", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh K. Khemani", "age": 63, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 456820, "exercisedValue": 0, "unexercisedValue": 3799157}, {"maxAge": 1, "name": "Dr. Dmitri V. Lissin M.D.", "age": 63, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 528826, "exercisedValue": 0, "unexercisedValue": 3054720}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.31, "open": 1.32, "dayLow": 1.312, "dayHigh": 1.48, "regularMarketPreviousClose": 1.31, "regularMarketOpen": 1.32, "regularMarketDayLow": 1.312, "regularMarketDayHigh": 1.48, "beta": 0.772, "forwardPE": -2.4727273, "volume": 1821671, "regularMarketVolume": 1821671, "averageVolume": 918220, "averageVolume10days": 1776630, "averageDailyVolume10Day": 1776630, "bidSize": 3200, "askSize": 1000, "marketCap": 225715136, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 16.9, "priceToSalesTrailing12Months": 4.9936976, "fiftyDayAverage": 1.7485, "twoHundredDayAverage": 3.101765, "currency": "USD", "enterpriseValue": 253778192, "profitMargins": -2.45166, "floatShares": 33826406, "sharesOutstanding": 165967008, "sharesShort": 7195140, "sharesShortPriorMonth": 5959176, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0456, "heldPercentInsiders": 0.39972, "heldPercentInstitutions": 0.16853, "shortRatio": 12.53, "shortPercentOfFloat": 0.0756, "bookValue": -1.728, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -163460000, "trailingEps": -1.16, "forwardEps": -0.55, "enterpriseToRevenue": 5.615, "enterpriseToEbitda": -2.471, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SCLX", "underlyingSymbol": "SCLX", "shortName": "Scilex Holding Company", "longName": "Scilex Holding Company", "firstTradeDateEpochUtc": 1614954600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ea412020-7b31-3199-90c2-cf75b3e7ae39", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.36, "targetHighPrice": 12.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.83, "targetMedianPrice": 4.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 1954000, "totalCashPerShare": 0.02, "ebitda": -102686000, "totalDebt": 125343000, "quickRatio": 0.08, "currentRatio": 0.111, "totalRevenue": 45200000, "revenuePerShare": 0.322, "returnOnAssets": -0.78876, "freeCashflow": -136821744, "operatingCashflow": -16042000, "revenueGrowth": -0.111, "grossMargins": 0.65325, "ebitdaMargins": -2.27181, "operatingMargins": -3.8356202, "financialCurrency": "USD", "trailingPegRatio": null}]